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Objective: Functional neuroimaging techniques represent fundamental tools in the context of
translational research integrating neurobiology, psychopathology, neuropsychology, and therapeutics.
In addition, cognitive-behavioral therapy (CBT) has proven its efficacy in the treatment of anxiety
disorders and may be useful in phobias. The literature has shown that feelings and behaviors are
mediated by specific brain circuits, and changes in patterns of interaction should be associated with
cerebral alterations. Based on these concepts, a systematic review was conducted aiming to evaluate
the impact of CBT on phobic disorders measured by functional neuroimaging techniques.
Methods: A systematic review of the literature was conducted including studies published between
January 1980 and April 2012. Studies written in English, Spanish or Portuguese evaluating changes in
the pattern of functional neuroimaging before and after CBT in patients with phobic disorders were
included.
Results: The initial search strategy retrieved 45 studies. Six of these studies met all inclusion criteria.
Significant deactivations in the amygdala, insula, thalamus and hippocampus, as well as activation of
the medial orbitofrontal cortex, were observed after CBT in phobic patients when compared with
controls.
Conclusion: In spite of their technical limitations, neuroimaging techniques provide neurobiological
support for the efficacy of CBT in the treatment of phobic disorders. Further studies are needed to
confirm this conclusion.
Keywords: Phobia; cognitive therapy; functional magnetic resonance imaging; positron-
emission tomography
Introduction
Functional neuroimaging techniques, such as magnetic
resonance imaging (fMRI), single-photon emission-com-
puted tomography (SPECT), spectroscopy, diffusion
tensor imaging (DTI), and positron-emission tomography
(PET), represent fundamental tools for translational
research. These techniques allow the integration of
neurobiology, psychopathology, neuropsychology, and
therapeutics, contributing significantly to the understand-
ing of the neurobiology of emotional regulation in healthy
individuals and the neurocircuitry involved in the patho-
physiology of mental disorders.1 Phobic disorders are
characterized by marked and persistent fear prompted by
a specific object or situation, and accompanied by the
compelling effort to avoid such object or situation.2 Social
phobia, or social anxiety disorder (SAD), has a lifetime
prevalence rate of over 10% and is characterized by a
relevant fear of social or performance situations involving
possible scrutiny by others.3,4 Specific phobias (SP) are
also frequent, with a lifetime prevalence of 7-11%, and
are marked by excessive and unreasonable fear of
specific objects or situations such as animals (e.g.,
spiders, snakes, dogs, and mice), flying, driving, enclosed
places, heights, and blood/injury. Fear and avoidance
cause significant distress and/or impairment in occupa-
tional, academic, or social functioning.4,5 SP and SAD
appear to alter different neural circuits,6 and data from
neuroimaging studies and clinical trials suggest that
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pharmacotherapy and cognitive-behavioral therapy
(CBT) have positive effects on SAD. In SP, CBT may
be one of the few useful interventions.7,8 A combination of
Beck’s theoretical model and behavioral techniques, such
as exposition and systematic desensitization, synthetizes
CBT used in phobic disorders.1
Studies involving fMRI in SP patients have demon-
strated increased activation of the amygdala, anterior
cingulate cortex (ACC), insular cortex, thalamus, and
visual areas in patients exposed to or anticipating the
presentation of phobic stimulation.9-11 Such regions are
the same as those involved in the pathophysiology of
SAD observed in other functional neuroimaging studies.9
Moreover, a meta-analysis observed hyperactivation of
the amygdala and insula in patients with SAD and SPs.10
Considering the correspondence between changes in
brain and behavior, we aimed to systematically review the
literature regarding clinical trials using functional neuroi-
maging techniques to assess the response to CBT in
phobic disorders.
Methods
Three investigators (AGA, AB, CT) independently
searched the databases of PubMed and ISI Web of
Knowledge. Their search included clinical trials evaluat-
ing the changes in the pattern of functional neuroimaging
methods before and after CBT for phobic disorders,
published from January 1980 to April 2012. The keywords
used in the search were functional magnetic resonance
imaging or positron-emission tomography or single-
photon emission-computed tomography or spectroscopy
or diffusion tensor imaging and phobic disorders or
phobia and cognitive therapy or behavior therapy. An
initial searching protocol was prepared considering the
following inclusion criteria: 1) studies written in English,
Spanish or Portuguese; 2) clinical trials using any
cognitive-behavioral technique for phobias; 3) diagnosis
of phobia in patients over 18 years of age, and exclusion
of any other psychiatric diagnosis based on a structured
clinical diagnostic interview or according to the DSM-IV
criteria4; 4) a functional neuroimaging method used
before and after the psychotherapeutic intervention, with
a symptom provocation paradigm; 5) presence of a
control group.
Results
The initial search strategy yielded 45 studies. Forty-one
of them (91.1%) were published in English, Spanish or
Portuguese, which were screened for relevance related to
the topic. Thirty-five studies (85.4%) were excluded for
the following reasons: 21 were review studies; four
consisted of reports on meeting presentations; five
focused on other disorders (two on generalized anxiety
disorder, one on panic disorder, one on posttraumatic
stress disorder, and one on irritable bowel syndrome);
finally, five studies did not perform CBT as an interven-
tion. The systematic literature review search process and
final results are shown in Figure 1. Six studies met all
inclusion criteria. All of those studies were prospective
and had a control group of non-phobic patients. Phobic
patients were allocated in two groups: those submitted to
CBT and a waiting list group. Patients and controls were
submitted to a functional neuroimaging method before
treatment, and all phobic patients (including those in the
waiting lists) were submitted to a functional neuroimaging
method after CBT. Comparisons were made between
phobic patients and controls before treatment, and
between patients who were submitted to CBT vs. waiting
list patients. Blindness of imaging analysis was not
declared in none of the studies. Overall, phobic patients
presented higher activations of the amygdala, insula,
thalamus and hippocampus, as well as lower activation of
the medial orbitofrontal cortex (OFC) compared with a
healthy control group. In addition, significant deactiva-
tions of the amygdala, insula, thalamus and hippocam-
pus, as well as activation of the medial OFC, were
observed in phobic patients after CBT when compared
with controls (waiting list group). Those changes in brain
activity were correlated with improvements of phobic
symptoms. Table 1 summarizes the main characteristics
and results of these studies included in the review.
Discussion
Previous studies have suggested that the mental func-
tions and processes involved in CBT exert a significant
influence on brain functioning and plasticity. Furthermore,
functional neuroimaging studies have contributed to the
understanding of the pathophysiological mechanisms
underlying phobic disorders, thus providing an objective
parameter to evaluate the impact of psychotherapeutic
approaches and other non-pharmacological interven-
Figure 1 Systematic literature review search process and
final results
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tions.1,11-13,15-18 Over the past decades, CBT has
demonstrated good efficacy in treating most anxiety
disorders, including phobias.7,8 Individuals with phobias
exposed to phobic stimuli showed increased amygdala,
ACC, and insular cortex activation in functional neuroi-
maging studies when compared with healthy controls.5
Reduced amygdala and insula and increased medial
OFC activations after a successful CBT treatment are in
agreement with expected cognitive and emotional
changes. Amygdala activity modulates vigilance, which,
in turn, facilitates an increased attentional interest in
environmental factors in order to acquire information to
resolve the ambiguity.14,16,19,20 As the amygdala has
been related to the pathophysiology of phobias, a
reduction in the symptoms of autonomic arousal could
be represented by reduced amygdala activity measured
by functional neuroimaging methods.14,19,20 Moreover,
the insular cortex has been shown to be generally
involved in the recognition and experience of aversive
states, such as disgust, fear, and pain, and it is possible
that successful CBT reduces the need to decode
unpleasant emotional states usually related to exposure
to phobic stimuli.14 In addition, since the medial prefrontal
cortex (MPFC) is involved in processes associated with
extinction of conditioned fear, an increased activity in
these areas could result in remission of emotion-related
neural responses.21
We found that all clinical trials using functional neuroima-
ging techniques to assess the CBT response in phobic
disorders found significant deactivation of the amygdala,
insula, thalamus, and hippocampus, as well as activation of
the medial OFC, after CBT in phobic patients when
compared with controls. As these regions have been
associated with the pathophysiology of either SP or SAD,
deactivations of such areas after CBT would be a possible
marker of improvement.14,19,20 Such findings, which are
similar to those observed in functional neuroimaging
studies of phobic patients treated with antidepressants,22,23
could support the efficacy of CBT in the treatment of
phobias.6,12-21 Moreover, recent studies have observed
that functional brain imaging may detect biomarkers that
substantially improve predictions for the success of
cognitive-behavioral interventions, suggesting that such
biomarkers could offer personalized approaches for opti-
mally selecting among treatment options for a patient.24
Finally, a number of important limitations need to be
considered, such as the reduced number of studies found
in the literature and their small sample size. Moreover,
differences across the studies precluded a direct com-
parison between them. Such heterogeneities were
related to the phobic disorders examined, neuroimaging
techniques used, data analysis methods, number of
subjects, nature of volunteer controls, condition of data
acquisition (resting state, activation task), and timing of
the second imaging study during treatment. Although
anxiety disorders are more prevalent in women, the
studies had a gender limitation because all simple phobia
patients were women, thus preventing generalization of
results. In addition, the studies included in the present
review did not allow determining whether the brain
changes measured after psychotherapy were the cause
or the effect of symptom reduction.
Nevertheless, despite such technical limitations, current
literature data provide a possible neurobiological support
for the efficacy of CBT in phobic disorders measured by
functional neuroimaging studies.12-21 Further complemen-
tary and longitudinal studies with larger and homogeneous
samples, comparing different functional neuroimaging
techniques in the same sample, are needed to better
understand the underlying pathogenesis of phobic dis-
orders and the efficacy of CBT in this context.6
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